Evidence map›Paper›PMID 39492689›Full record

ArticleAnnals of medicine2024

Assessing the influence of COVID-19 pandemic on thirty days readmission rate based on patient's demographics, substance use, and insurance.

Bashar Khiatah, Pooja Gajjar, Andrew Sous, Lara Aboud Syriani, Cindy Kim, Wisam Razook, Graal Diaz, Deborah Carlson

Abstract read
In one paragraph

Article in Annals of medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bashar KhiatahInternal Medicine Department, Overlake Medical Center, Bellevue, WA, USA.ORCID 0000-0002-6870-8094
Pooja GajjarInternal Medicine Department, Loma Linda University, Loma Linda, CA, USA.
Andrew SousInternal Medicine Department, Community Memorial Hospital, Ventura, CA, USA.
Lara Aboud SyrianiObstetrics and Gynecology Department, University of Loma Linda, Loma Linda, CA, USA.
Cindy KimDepartment of Medicine, Saint Elizabeth Medical Center, Brighton, MA, USA.
Wisam RazookDepartment of internal medicine, University of Arizona, Tucson, AZ, USA.
Graal DiazProgram Director of Internal Medicine Department, Community Memorial Hospital, Ventura, CA, USA.ORCID 0000-0002-5556-1636
Deborah CarlsonClinical Translational Researcher and Faculty, Graduate Medical Education, Community Memorial Hospital, Ventura, CA, USA.ORCID 0000-0001-7886-5168

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Providing the highest quality care with no biases is the goal of every healthcare system. As a part of that goal hospital readmission has been investigated due to its impact on healthcare cost and case fatality rate in patient outcome. Patient's demographics, substance use and insurance barriers have been investigated as factors for readmission rate but the impact of COVID-19 pandemic on those biases and barriers have not been studied extensively yet. In our retrospective cross-sectional study, we placed the scope on readmission rate with the intention to investigate any relation with patient's demographics including ethnicity, gender, language, substance use and insurance barriers and if there has been any change in the area pre and post COVID-19 pandemic. Total of 1713 readmitted patients were identified and split into 893 pre-COVID-19 and 820 post COVID-19 pandemic. Our multivariable analysis showed that the rate of readmissions during the COVID-19 pandemic was statistically higher among substance users (

Indexed as

COVID-19Patient ReadmissionSubstance-Related DisordersAdultAgedCross-Sectional StudiesFemaleHumansInsurance, HealthMaleMedicaidMiddle AgedPandemicsRetrospective StudiesSARS-CoV-2United StatesCOVID-19 biasisReadmissionsubstance use

Identifiers

PMID39492689
PMCPMC11616754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.